Abstract:One approach to experimental science involves creating hypotheses, then testing them by varying one or more independent variables, and assessing the effects of this variation on the processes of interest. We use this strategy to compare the intellectual status and available evidence for two models or views of mechanisms of transmembrane drug transport into intact biological cells. One (BDII) asserts that lipoidal phospholipid Bilayer Diffusion Is Important, while a second (PBIN) proposes that in normal intact cells Phospholipid Bilayer diffusion Is Negligible (i.e., may be neglected quantitatively), because evolution selected against it, and with transmembrane drug transport being effected by genetically encoded proteinaceous carriers or pores, whose "natural" biological roles, and substrates are based in intermediary metabolism. Despite a recent review elsewhere, we can find no evidence able to support BDII as we can find no experiments in intact cells in which phospholipid bilayer diffusion was either varied independently or measured directly (although there are many papers where it was inferred by seeing a covariation of other dependent variables). By contrast, we find an abundance of evidence showing cases in which changes in the activities of named and genetically identified transporters led to measurable changes in the rate or extent of drug uptake. PBIN also has considerable predictive power, and accounts readily for the large differences in drug uptake between tissues, cells and species, in accounting for the metabolite-likeness of marketed drugs, in pharmacogenomics, and in providing a straightforward explanation for the late-stage appearance of toxicity and of lack of efficacy during drug discovery programmes despite macroscopically adequate pharmacokinetics. Consequently, the view that Phospholipid Bilayer diffusion Is Negligible (PBIN) provides a starting hypothesis for assessing cellular drug uptake that is much better supported by the available evidence, and is both more productive and more predictive.

Recent advances in methods for quantifying the cell penetration of macromolecules

Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization

Comparing cell penetration of biotherapeutics across human cell lines

Recent Advances in the Determination of Intracellular Contents in Individual Cells Using Microfluidic Devices

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics

A Quantitative Method To Distinguish Cytosolic From Endosome‐Trapped Cell‐Penetrating Peptides

Quantitative fluorescence spectroscopy and flow cytometry analyses of cell-penetrating peptides internalization pathways: optimization, pitfalls, comparison with mass spectrometry quantification

Recent Advancements in Single-Cell Metabolic Analysis for Pharmacological Research

Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design

Recent Advances of Studies on Cell-Penetrating Peptides Based on Molecular Dynamics Simulations

Single-Cell Biochemical Assays For The Molecular Targets Of Disease

Microfluidic Based Physical Approaches Towards Single-Cell Intracellular Delivery and Analysis

Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay

Measuring the Enzymatic Activity of Clinically Important Proteins in Single Cells

Quantitative Analysis of Different Cell Entry Routes of Actively Targeted Nanomedicines Using Imaging Flow Cytometry.

How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion

Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool.

Real‐Time Quantification of Cell Internalization Kinetics by Functionalized Bioluminescent Nanoprobes

In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides